Home » Stocks » BIVI

BioVie, Inc. (BIVI)

Stock Price: $34.26 USD -3.25 (-8.66%)
Updated Jan 27, 2021 2:43 PM EST - Market open
Market Cap 490.13M
Revenue (ttm) n/a
Net Income (ttm) -59.12M
Shares Out 5.97M
EPS (ttm) -10.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $34.26
Previous Close $37.51
Change ($) -3.25
Change (%) -8.66%
Day's Open 36.70
Day's Range 33.38 - 37.25
Day's Volume 50,498
52-Week Range 7.85 - 42.09

News

There are no news available yet.

About BIVI

BioVie, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. It develops BIV201, which completed Phase 2a clinical trial for the treatment of ascites due to chronic liver cirrhosis. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was founded in 2013 and is based in Santa Monica, California.

Industry
Biotechnology
Founded
2013
CEO
Terren S. Peizer
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
BIVI
Full Company Profile

Financial Performance

Financial Statements